Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Versatile and Robust Method for Antibody Conjugation to Nanoparticles with High Targeting Efficiency

Pharmaceutics(2021)10.3390/pharmaceutics13122153Source: DataRank Database

Versatile and Robust Method for Antibody Conjugation to Nanoparticles with High Targeting Efficiency is a research paper published in Pharmaceutics (2021). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: goldTopics (23)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

María Loreto Bravo ORCID,Olivier Deschaume ORCID,Pierre Cybulski ORCID,Carmen Bartic ORCID,Johan Hofkens ORCID

Live enrichment

PubMed:34959436 PMC:PMC8703776

Marie Curie

Grant: 860914

SuperCol: Rational design of super-selective and responsive colloidal particles for biomedical applications

Research Foundation - Flanders

Grant: 12X1419N

Research Foundation - Flanders

Grant: 1529418N

Japan Society for the Promotion of Science

Grant: Core-to-Core program

Research Foundation - Flanders

Grant: G0D4519N

Research Foundation - Flanders

Grant: 11F5419N

Research Foundation - Flanders

Grant: G094717N

KU Leuven

Grant: C14/18/061

KU Leuven

Grant: KA/20/026

Methusalem

Grant: Meth/15/04

KU Leuven

Grant: C14/16/053

Research Foundation - Flanders

Grant: G0A5817N

goldLicense: CC BY

Europe_PMChttps://europepmc.org/articles/PMC8703776

Europe_PMChttps://europepmc.org/articles/PMC8703776?pdf=render

https://doi.org/10.1101/2021.09.29.462399

https://lirias.kuleuven.be/bitstream/20.500.12942/687114/2/pharmaceutics-13-02153%281%29.pdf

https://doi.org/10.3390/pharmaceutics13122153

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Mesoporous Silica NanoparticlesTargeted Drug Delivery SystemsAntibody FunctionalizationScience & TechnologyENHANCED PERMEABILITYEGFR3214 Pharmacology and pharmaceutical sciencesCELLULAR UPTAKEIN-VITROPROSPECTIVE IDENTIFICATIONArticleRS1-441Pharmacy and materia medicaGOLD NANOPARTICLESPharmacology & PharmacyDRUG-DELIVERYCANCER-CELLSCD441115 Pharmacology and Pharmaceutical SciencesLife Sciences & Biomedicine

Sustainable Development Goals

SDG 3: 3. Good health